The magnesium rabbit hole is deep, and honestly frustrating — because for years the advice was just 'take magnesium' with no nuance at all. Women were buying oxide, which barely absorbs, or switching forms every few months without knowing why one worked better than another. The glycinate vs. threonate distinction is one of the few supplement conversations that actually has enough science behind it to feel like solid ground.
Learn more about Rose →Magnesium glycinate is magnesium bound to glycine, an amino acid, which allows it to be absorbed through intestinal amino acid transporters rather than the ion channels that standard magnesium salts rely on. This makes it significantly better tolerated and absorbed in the gut compared to forms like oxide or citrate. Magnesium threonate, on the other hand, is bound to threonic acid, a metabolite of vitamin C, and this specific bond appears to facilitate transport across the blood-brain barrier — a pathway that glycinate does not meaningfully exploit.
Animal studies and early human trials suggest that magnesium threonate is the only oral form demonstrated to meaningfully increase magnesium concentrations in cerebrospinal fluid and brain tissue. This distinction matters because general serum magnesium levels — the kind measured in a standard blood test — do not reliably reflect brain magnesium status. For women whose primary concerns are cognitive symptoms like memory lapses, word-finding difficulty, or mental fatigue, this central nervous system penetration is the key differentiator.
Glycine, the amino acid carrier in magnesium glycinate, has its own independent sleep-promoting properties — it acts on NMDA receptors and has been shown in small RCTs to lower core body temperature and reduce time to sleep onset. Because magnesium glycinate delivers both magnesium and glycine simultaneously, it addresses two separate mechanisms relevant to the disrupted, non-restorative sleep that is one of the most common and disabling symptoms of perimenopause. Threonate may also support sleep through its effects on synaptic plasticity, but the direct evidence for sleep outcomes is currently thinner.
Glycine functions as an inhibitory neurotransmitter in the spinal cord and brainstem, and magnesium itself modulates NMDA receptor activity — both mechanisms that support a calmer nervous system. This dual action makes magnesium glycinate a particularly logical choice for the anxiety, irritability, and nervous tension that track with estrogen fluctuations in perimenopause. Magnesium threonate also has anxiolytic potential through its effects on synaptic density, but its primary research focus has been cognitive rather than anxiolytic outcomes.
Magnesium plays a direct role in muscle relaxation by competing with calcium at neuromuscular junctions — without adequate magnesium, muscles are more prone to involuntary contraction and cramping. Magnesium glycinate delivers a high elemental magnesium dose per capsule with good bioavailability, making it well suited for women dealing with night leg cramps, jaw tension, or the generalised muscle tightness that often worsens in perimenopause. Threonate typically delivers a lower dose of elemental magnesium per serving because the threonic acid molecule is heavier, making it a less efficient vehicle for addressing whole-body magnesium depletion.
The weight of the carrier molecule determines how much actual magnesium arrives in each capsule or tablet. Magnesium glycinate typically provides around 14% elemental magnesium by weight, while magnesium threonate — because threonic acid is a heavier molecule — provides only around 7–8% elemental magnesium per gram of compound. This means a woman would need to take roughly twice as many capsules of threonate to match the raw magnesium dose of glycinate, which is a practical consideration for anyone managing multiple supplements or watching pill burden.
The original case for magnesium threonate was built on research from MIT showing that raising brain magnesium levels improved synaptic plasticity and reversed age-related cognitive decline in animal models. Subsequent small human trials have suggested improvements in executive function, attention, and episodic memory in older adults. For women in early postmenopause who are concerned about the long-term cognitive trajectory — not just day-to-day brain fog — threonate represents a more targeted and better-reasoned choice than glycinate.
One of the most common reasons women stop taking magnesium is digestive distress — specifically the loose stools caused by forms like oxide and citrate drawing water into the colon. Magnesium glycinate is widely regarded as the most gut-friendly form available, with very low rates of laxative effect at therapeutic doses, because it is absorbed before reaching the large intestine. Magnesium threonate is also generally well tolerated, but because it is a newer and less widely studied compound, the long-term tolerance data across diverse populations is thinner than the evidence base for glycinate.
Magnesium threonate is a patented compound (commonly sold under proprietary names) and commands a substantially higher retail price than magnesium glycinate — often two to four times more per month of supply. Glycinate is an off-patent, commodity ingredient produced by many manufacturers and available in most health food stores, pharmacies, and online retailers. For women who need broad magnesium repletion — addressing sleep, muscle cramps, and anxiety together — glycinate offers better value; threonate is a more targeted investment that makes most sense when cognitive support is the specific, primary goal.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.